Elizabeth Barr PhD, MPH

Elizabeth Barr is a senior epidemiologist within the DIABETES across the LIFECOURSE: Northern Australian Partnership. She holds appointments at Menzies School of Health Research, Charles Darwin University, and Baker Heart and Diabetes Institute. Her PhD work provided the first Australian national data on the cardiovascular and mortality risks associated with diabetes and intermediate hyperglycaemia, with findings providing an important rationale for developing diabetes prevention programs. Dr. Barr's work also contributed to international consortiums: The Emerging Risk Factor Collaboration, headed by a Cambridge University group; and specifically as a means of validating the Globorisk international cardiovascular risk score. She received the 2021 Australian Diabetes Society Jeff Flack Diabetes Data Award for development of epidemiological data systems for chronic conditions. Elizabeth established the Cardiovascular Risk in IndigenouS People (CRISP) study, a collaboration of five epidemiological studies of Aboriginal and Torres Strait Islander Peoples, a key translational project, and collaborates on the NHMRC funded projects: The eGFR3 study and the Pregnancy And Neonatal Outcomes in Remote Australia (PANDROA) studies. Dr. Barr works in partnership with several Aboriginal and Torres Strait Islander community stakeholders to embed community support and priorities within research and translation strategies to improve the lives of people with diabetes, especially Aboriginal and Torres Strait Islander Peoples. She is committed to capacity building in public health and epidemiology, and provides mentorship to research staff and students.